PRO/AH/EDR> COVID-19 update (244): lambda var S America, long COVID & children, Europe, WHO

COVID-19 — Worldwide/Unknown
1. Tada T, Zhou H, Dcosta BM, et al. SARS-CoV-2 lambda variant remains susceptible to neutralization by mRNA vaccine-elicited antibodies and convalescent serum. bioRxiv. 2021.
2. Acevedo ML, Alonso-Palomares L, Bustamante A, et al. Infectivity and immune escape of the new SARS-CoV-2 variant of interest lambda. medRxiv. 2021.
[Byline: Sanjay Mishra]

Communicated by:
ProMED

******
[2] Long COVID in children
Date: Wed 14 Jul 2021
Source: Nature [edited]

As COVID-19